Group 4

Notice convening the Annual General Meeting of AB Electrolux

Retrieved on: 
Friday, February 16, 2024

The Board of Directors proposes that the following guidelines for remuneration shall be approved by the Annual General Meeting of the Company.

Key Points: 
  • The Board of Directors proposes that the following guidelines for remuneration shall be approved by the Annual General Meeting of the Company.
  • The principles shall be applied to employment and consultancy agreements entered into after the 2024 Annual General Meeting, and to changes made to existing agreements thereafter.
  • The proposal to the 2024 Annual General Meeting for resolution on guidelines for remuneration corresponds, in all material aspects, with the guidelines adopted by the 2020 Annual General Meeting.
  • The resolution of the Annual General Meeting to implement the Share Program 2024 according to a) above requires that more than half of the votes cast at the Annual General Meeting are in favor of the proposal.

Notice convening the Annual General Meeting of AB Electrolux

Retrieved on: 
Friday, February 16, 2024

The Board of Directors proposes that the following guidelines for remuneration shall be approved by the Annual General Meeting of the Company.

Key Points: 
  • The Board of Directors proposes that the following guidelines for remuneration shall be approved by the Annual General Meeting of the Company.
  • The principles shall be applied to employment and consultancy agreements entered into after the 2024 Annual General Meeting, and to changes made to existing agreements thereafter.
  • The proposal to the 2024 Annual General Meeting for resolution on guidelines for remuneration corresponds, in all material aspects, with the guidelines adopted by the 2020 Annual General Meeting.
  • The resolution of the Annual General Meeting to implement the Share Program 2024 according to a) above requires that more than half of the votes cast at the Annual General Meeting are in favor of the proposal.

BlackKite sensor flies on U.S. Army Group 4 UAS at EDGE 23 demonstration event

Retrieved on: 
Thursday, June 8, 2023

FAIRFAX, Va., June 8, 2023 /PRNewswire/ -- Logos Technologies LLC, a subsidiary of Elbit Systems of America, announced today that its BlackKite IR wide-area motion imagery (WAMI) pod was, for the first time ever, successfully employed on a U.S. Army Group 4 unmanned aircraft system (UAS) during the Experimentation Demonstration Gateway Event (EDGE) 23, held at Yuma Proving Ground, Arizona, this past month.

Key Points: 
  • "We demonstrated how our lightweight BlackKite pod could be used in the long-range detection of enemy vehicles and air defense systems," said Doug Rombough, VP of Business Development at Logos Technologies.
  • "And even though the Group 4 UAS was only meant to serve as a surrogate for ALE, we also showed how our platform-agnostic BlackKite pod could work with long-endurance Group 4 UAS."
  • BlackKite weighs less than 38 pounds in the podded version and can been mounted to planes, helicopters, and Group 3 (or larger) UAS.
  • When BlackKite is placed inside an existing payload bay, it only adds 25 pounds to the platform.

Vaccitech Provides Update on Ongoing VTP-300 Phase 1b/2a Trial Showing Sustained Reductions of HBsAg in Patients with Chronic Hepatitis B

Retrieved on: 
Monday, November 7, 2022

OXFORD, United Kingdom, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapies and vaccines for the treatment and prevention of infectious diseases, cancer, and autoimmune diseases, today announced an update to the interim analysis of safety and efficacy data from its HBV002 trial (NCT04778904). The data will be presented as a poster at the 2022 American Association for the Study of Liver Disease (AASLD) - The Liver Meeting® by Dr. Young-Suk Lim, Professor of the Department of Gastroenterology and the Liver Center, Asian Medical Center, University of Ulsan College of Medicine, Korea.

Key Points: 
  • VTP-300 induced sustained reductions of hepatitis B surface antigen in people with chronic hepatitis B during ongoing, fully enrolled Phase 1b/2a trial.
  • Vaccitechs updated interim analysis includes data from the fully-enrolled trial of 55 patients with chronic hepatitis B (HBV) with at least three months of follow-up.
  • It shows that VTP-300 induced meaningful, sustained reductions of HBV surface antigen (HBsAg) in people with chronic HBV.
  • Enrollment in the HBV002 trial is complete, with a final update expected early in the second quarter of 2023.

Canadian Coast Guard Conducts Offshore Sea Trials of VTOL UAS with Shield AI and Kongsberg Geospatial

Retrieved on: 
Wednesday, January 26, 2022

The Canadian Coast Guard is conducting trials of the long-endurance Vertical Take-of and Landing (VTOL) UAS surveillance system for possible deployment on Canadian Coast Guard Vessels under a project funded by Defence Research and Development Canada (DRDC).

Key Points: 
  • The Canadian Coast Guard is conducting trials of the long-endurance Vertical Take-of and Landing (VTOL) UAS surveillance system for possible deployment on Canadian Coast Guard Vessels under a project funded by Defence Research and Development Canada (DRDC).
  • Kongsberg Geospatial teamed with Shield AI to deploy the V-BAT VTOL UAS for a 3-day sea trial in international waters in the Gulf of Mexico.
  • This series of endurance trials is the second set of flight trials of the Shield AI V-BAT conducted by the Canadian Coast Guard.
  • For more information visit: Shield.AI
    About the Canadian Coast Guard: Headquartered in Ottawa, the Canadian Coast Guard ( https://www.ccg-gcc.gc.ca/index-eng.html ) is the coast guard of Canada.

Martin UAV Kicks Off MTUAS Increment 2 Effort with Naval Air Warfare Center Aircraft Division

Retrieved on: 
Tuesday, November 16, 2021

SAN DIEGO, Nov. 16, 2021 /PRNewswire/ -- Shield AI , the defense-technology company using self-driving software to enable collaborative teams of unmanned aircraft to operate in GPS- and RF-denied environments, announced today that Martin UAV (a Shield AI company) kicked off its Multi-Mission Tactical UAS Increment 2 (Mi2) prototype effort with Naval Air Warfare Center Aircraft Division (NAWCAD) on Oct. 19.

Key Points: 
  • SAN DIEGO, Nov. 16, 2021 /PRNewswire/ -- Shield AI , the defense-technology company using self-driving software to enable collaborative teams of unmanned aircraft to operate in GPS- and RF-denied environments, announced today that Martin UAV (a Shield AI company) kicked off its Multi-Mission Tactical UAS Increment 2 (Mi2) prototype effort with Naval Air Warfare Center Aircraft Division (NAWCAD) on Oct. 19.
  • "We couldn't be more excited about the partnership with NAWCAD on MTUAS.
  • Each system delivered will follow the pattern of equipment delivery, personnel training, and a government test event, supported by Martin UAV personnel.
  • Martin UAV (a Shield AI company) specializes in building wholly unique, unmanned aircraft systems and associated flight control software.

AGTC Announces Financial Results and Business Update for the Quarter Ended September 30, 2021

Retrieved on: 
Tuesday, November 9, 2021

GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare inherited retinal diseases (IRDs), today announced financial results for the quarter ended September 30, 2021.

Key Points: 
  • Based on these data, AGTC intends to advance the ACHMB3 program to the next stage of clinical development.
  • Financial Results for the Quarter EndedSeptember 30, 2021
    R&D Expenses: Research and development expenses were $12.3 million for the quarter ended September 30, 2021 compared to $11.6 million during the same period in the prior year.
  • G&A Expenses:General and administrative expenses were $4.1 million for the quarter ended September 30, 2021 compared to $3.4 million during the same period in the prior year.
  • Actual results could differ materially from those discussed in the forward-looking statements, due to a number of important factors.

V-BAT Takes Flight with 11th Marine Expeditionary Unit aboard USS Portland

Retrieved on: 
Thursday, October 7, 2021

The V-BAT UAS provides a critical reconnaissance, surveillance, and target acquisition (RSTA) capability for the Navy and Marine Corps in a unique environment where space is at a premium.

Key Points: 
  • The V-BAT UAS provides a critical reconnaissance, surveillance, and target acquisition (RSTA) capability for the Navy and Marine Corps in a unique environment where space is at a premium.
  • Aboard USS Portland, the unmanned aircraft performed and proved durable in high winds and challenging weather conditions.
  • Propelled by a single, ducted, thrust-vectored fan, it takes off and lands in the style of a SpaceX rocket.
  • Martin UAV (a Shield AI company) specializes in building wholly unique, unmanned aircraft systems and associated flight control software.

William Murray Acquires Shares from Fortuna Silver Mines Inc.

Retrieved on: 
Wednesday, September 8, 2021

Vancouver, British Columbia--(Newsfile Corp. - September 7, 2021) - William Murray ("Murray"), a director of Keon Capital Inc. ("Keon") (TSXV: KEON.H) announced today that he acquired (the "Acquisition") 215,365 common shares (the "Purchased Shares") of Keon from Fortune Silver Mines Inc. ("Fortuna") at a price of $0.10 per Purchased Share for an aggregate purchase price of $21,536.50 pursuant to a share purchase agreement entered into between Murray and Fortuna on September 7, 2021.

Key Points: 
  • Vancouver, British Columbia--(Newsfile Corp. - September 7, 2021) - William Murray ("Murray"), a director of Keon Capital Inc. ("Keon") (TSXV: KEON.H) announced today that he acquired (the "Acquisition") 215,365 common shares (the "Purchased Shares") of Keon from Fortune Silver Mines Inc. ("Fortuna") at a price of $0.10 per Purchased Share for an aggregate purchase price of $21,536.50 pursuant to a share purchase agreement entered into between Murray and Fortuna on September 7, 2021.
  • Prior to the Acquisition, Murray held 70,733 common shares directly and 23,033 common shares indirectly through his wholly-owned private company, Group 4 Ventures Ltd. ("Group 4"), for a combined holdings of 93,766 common shares of Keon, representing approximately 4.895% of the issued and outstanding common shares of Keon.
  • As a result of the Acquisition, Murray now holds, directly and indirectly through Group 4, a total of 309,131 common shares, representing approximately 16.136% of the issued and outstanding common shares of Keon.
  • Murray acquired the Purchased Shares for private investment purposes and may increase or decrease its beneficial ownership or control in Keon as circumstances or market conditions warrant.